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Abstract
The impact of organized screening programmes on colorectal cancer (CRC) can be observed at a pop-
ulation level only several years after the implementation of screening. We compared CRC character-
istics by diagnostic modality (screen-detected, non-screen-detected) as an early outcome to monitor
screening programme effectiveness.
Data on CRCs diagnosed in Italy from 2000 to 2008 were collected by several cancer registries. Link-
age with screening datasets made it possible to divide the cases by geographic area, implementation
of screening, and modality of diagnosis (screen-detected, non-screen-detected). We compared the main
characteristics of the different subgroups of CRCs through multivariate logistic regression models.
The study included 23,668 CRCs diagnosed in subjects aged 50-69 years, of which 11.9% were screen-
detected (N=2,806), all from the North-Centre of Italy. Among screen-detected CRCs, we observed a
higher proportion of males, of cases in the distal colon, and a higher mean age of the patients. Com-
pared with pre-screening cases, screen-detected CRCs showed a better distribution by stage at diag-
nosis (OR for stage III or IV: 0.40, 95%CI: 0.36-0.44) and grading (OR for poorly differentiated CRCs
was 0.86, 95%CI: 0.75-1.00).
Screen-detected CRCs have more favourable prognostic characteristics than non-screen-detected cases.
A renewed effort to implement screening programmes throughout the entire country is recommended.
(Epidemiol Prev 2015; 39(3) Suppl 1: 108-114)
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Riassunto
L’impatto dei programmi di screening del tumore del colon retto (CRC) può essere osservato a li-
vello di popolazione solo alcuni anni dopo l’attivazione degli stessi. Abbiamo confrontato le ca-
ratteristiche dei CRC, suddivisi per modalità diagnostica (screen-detected, non-screen-
detected), come indicatore precoce di efficacia dei programmi di screening.
Sono stati raccolti da diversi Registri tumori i dati sui CRC diagnosticati in Italia dal 2000 al 2008.
Tramite linkage con gli archivi di screening è stata raccolta la modalità diagnostica dei casi, oltre al-
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INTRODUCTION
Colorectal cancer (CRC) survival is strictly related to the stage
at diagnosis, with a better prognosis for stage I compared to stage
III and IV.1 CRC screening with a biennial faecal occult blood
test (FOBT) has been shown to reduce mortality through the
early detection and treatment of cancer in large population-
based trials.2 Routine, organized screening programmes (SPs)
based on the faecal immunochemical test (FIT) have been
shown to achieve even better outcomes on mortality.3 Further-
more, there is some evidence that screening can also reduce in-
vasive colorectal cancer through the identification and treatment
of adenomas, preventing their transformation into cancer.4-6
The effects of screening can be observed at a population level
only several years after the implementation of screening and
only if SP participation is high. The stage at diagnosis of
screen-detected cancers is an interesting early outcome to
monitor screening programme effectiveness and predict the im-
pact on mortality, since a necessary condition to achieving a re-
duction in mortality in the short term is to detect cancer at an
earlier stage than clinically detected cancers.
With few exceptions, CRC SPs are aimed at Italian residents
aged 50 to 69 or 74 years who receive a mailed invitation to
undergo a single FIT every two years. Subjects with positive
screening tests are contacted to undergo a total colonoscopy at
an endoscopic referral centre. In only one region (Piemonte)
has a different programme been established, with either a flex-
ible sigmoidoscopy at the age of 58 or a FIT invitation every
2 years in the 59-69 years age range. The implementation of
CRC SPs started gradually in 2005-2006, and has been more
rapid in northern and central Italy than in the South. In 2008,
theoretical extension, (i.e., the proportion of the resident pop-
ulation aged 50-69 years living in areas covered by an SP), was
73.7% in the North, 56.3% in the Centre, and 21.4% in the
South and on the Islands (Sicilia and Sardegna).7
In order to describe the impact of implementing the CRC SPs
in Italy, the Italian Ministry of Health financed the IMPATTO
study, a research project that collected and linked information
from both SP archives and cancer registries.
In this paper, we used the IMPATTO study’s archives to
compare the characteristics of CRCs diagnosed in Italy from
2000 to 2008 by diagnostic modality (screen-detected, non-
screen-detected).
MATERIALS AND METHODS
Data
The data collected in the IMPATTO study database have been
described in the associated paper of this article.8 Briefly, for the
purpose of this paper, CRCs diagnosed in patients aged 50-69
years were selected and characterized according to the following
patterns of diagnosis:
 CRCs diagnosed in areas where an SP has been implemented:
 pre-screening (i.e., diagnosed before the onset of the SP);
 screen-detected;
 not screen-detected, diagnosed after the onset of the SP;
 CRCs diagnosed in areas where no SP has been implemented.
Analysis
The Chi square test was used to compare the distribution of
the main CRC characteristics included in the study by pattern
of diagnosis: anatomic sub-site, stage at diagnosis, grading,
number of lymph nodes examined and positive lymph nodes.
The association between pattern of diagnosis and CRC char-
acteristics was evaluated using logistic regression models which
included the variables that resulted significantly associated at
univariate analysis. In particular, we explored which factors
were associated with stage and grading, including the pattern
of diagnosis among the explanatory variables.
RESULTS
Overall, the study included 23,668 invasive cases of CRCs di-
agnosed in subjects aged 50-69 years between 2000 and 2008.
The cancer registries took part in the study with cases from dif-
ferent periods. Moreover, the SPs were introduced in different
years. In particular, the SPs were implemented in most areas
during 2005-2006, as opposed to Veneto (2002) and Firenze-
Prato, where SPs were already in place at the beginning of this
study. Finally, there were no SPs in the South and on the Islands
during the study period.
Table 2 (p. 110) shows the main characteristics by macro-area
and period: the North-Centre in 2000-2005 (before the SPs
became widespread), the North-Centre with SPs (2006-2008),
and the South and the Islands. The cases from the latter
macro-area represented about one-sixth of the overall study
(15.8%). As expected, the largest proportion of cases was
males (59%) from the older age group.
l’area geografica e alla presenza di un programma di screening organizzato. Abbiamo confrontato le principali caratteristiche
dei diversi sottogruppi di CRC tramite modelli di regressione logistica multivariata.
Lo studio riguarda 23.668 CRC diagnosticati in soggetti di età 50-69 anni, l’11,9% dei quali screen-detected (N=2.806),
tutti di aree del Nord o Centro Italia. Tra i casi screen-detected abbiamo osservato una maggiore proporzione di maschi, di
casi a carico del colon distale e un’età media più alta. Rispetto ai casi diagnosticati prima dell’attivazione degli screening, i
casi screen-detected avevano una migliore distribuzione per stadio alla diagnosi (odds ratio per stadio III o IV: 0,40; IC95%:
0,36-0,44) e grading (OR per grading scarsamente differenziato: 0,88; IC95%: 0,75-1,00).
I casi screen-detected avevano caratteristiche prognostiche migliori anche rispetto ai casi non-screen-detected. Si raccomanda
uno sforzo rinnovato per attivare programmi di screening colorettale in tutto il territorio nazionale.
(Epidemiol Prev 2015; 39(3) Suppl 1: 108-114)
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Macro-area Cancer registry Number of cases
2000 2001 2002 2003 2004 2005 2006 2007 2008 Total
Northwest Genova 312 294 283 889
Milano 449 456 415 427 399 367 452 2,965
Sondrio 47 41 54 50 48 54 73 77 67 511
Biella 64 54 64 57 67 54 63 423
Northeast Trentino 120 129 117 138 140 644
Veneto 138 155 166 188 179 162 988
Friuli-Venezia Giulia 418 395 369 1,182
Emilia-Romagna 137 240 629 954 1,334 1,519 1,994 1,565 385 8,757
Centre Firenze-Prato 341 343 319 322 323 319 1,967
Umbria 287 296 266 383 372 1,604
South-Islands Latina 126 129 108 132 495
Napoli 88 90 111 116 123 528
Siracusa 78 80 89 88 82 417
Palermo 268 261 258 787
Catania-Messina 318 366 368 1,052
Sassari 114 117 117 111 459
Figures in color represent the years when a screening programme was active
Table 1. Number of colorectal cancer cases by cancer registry and calendar year. Ages 50-69 years.
Tabella 1. Casi di tumore del colon retto per registro tumori e anno. Età 50-69 anni.
North-Centre 2000-2005 North-Centre 2006-2008 South and the Islands 2000-2008
N % N % p-value1 N % p-value1
Total 13,275 100 6,655 100 3,738 100
Gender
male 7,817 58.9 4,075 61.2 0.002 2,151 57.5 0.14
female 5,458 41.1 2,580 38.8 1,587 42.5
Age (years)
50-59 4,291 32.3 2,115 31.8 0.44 1335 35.7 <0.001
60-69 8,984 67.7 4,540 68.2 2,403 64.3
Pattern of diagnosis
screen-detected 569 4.3 2,237 33.6 <0.001 0 0 -
not screen-detected* 12,706 95.7 4,418 66.4 3,738 100
Anatomic site
proximal colon 3,557 26.8 1,776 26.7 <0.001 1,001 26.8 <0.001
distal colon 4,820 36.3 2,631 39.5 1,152 30.8
rectum 4,276 32.2 1,890 28.4 1,321 35.3
colon NOS** 622 4.7 358 5.4 7.1
Stage at diagnosis
I 2,146 16.2 1,878 28.2 <0.001 471 12.6 <0.001
II 3,299 24.9 1,518 22.8 905 24.2
III 3,817 28.8 1,598 24.0 852 22.8
IV 2,461 18.5 1,087 16.3 841 22.5
not available/missing 1,552 11.7 574 8.6 669 17.9
Grading
well-differentiated 1,165 8.8 935 14.0 <0.001 232 6.2 <0.001
moderately differentiated 7,792 58.7 3,740 56.2 2,290 61.3
poorly differentiated 1,981 15.0 1,178 17.7 531 14.2
not available/missing 2,337 17.6 802 12.1 685 18.3
1 p-value of Chi square test comparing the distribution by each variable in the table with the reference group = North-Centre, 2000-2005
* it includes pre-screening, not screen-detected in areas with screening, diagnosed in areas with no screening
** NOS: not otherwise specified
Table 2. Distribution of colorectal cancer cases according to main characteristics, by macro-area and period.
Tabella 2. Distribuzione dei casi di tumore del colon retto per varie caratteristiche, per macroarea e periodo.
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There were 2,806 screen-detected cases, or 11.9% of the
whole. This percentage rose to 33.6% in areas with an SP. One-
third of the cases (31.6%) were localized in the rectum.
The proportion of stage I cases and of cases with grade I was
highest in the North-Centre in 2006-2008 and lowest in the
South and on the Islands. Overall, the proportion of cases with
a stage missing at diagnosis was 11.8%.This was highest in the
South and on the Islands, and lowest in the North-Centre in
2006-2008.
Table 3 shows the characteristics of cases by pattern of diag-
nosis. Compared to the CRCs diagnosed during the pre-
screening period, screen-detected CRCs showed a different dis-
tribution for most variables. In particular, the proportion of
subjects aged 65-69 years was greater than 40% (41.7%), as
compared to 38.3%. Screen-detected cases were more fre-
quently located in the distal colon than pre-screening cancers
(50.6% vs 36.8%). Grading was more favourable, with 20.1%
of screen-detected cases being well-differentiated and only
11% poorly differentiated, compared respectively to 9.6%
and 15.6% in the pre-screening period. Also stage at diagno-
sis was less advanced: 42.8% of screen-detected cases were di-
agnosed at stage I (vs 16.2%) and only 6.2% at stage IV (vs
19.8%).
Finally, the number of lymph nodes examined in screen-detected
CRCs was similar to pre-screening cases (15.6 in both groups),
while the mean number of positive lymph nodes overall and for
cases stages III/IV was significantly lower in the former (1.0 vs
2.1 and 3.4 vs 4.2, respectively).
Both not screen-detected CRCs and CRCs diagnosed in areas
without screening showed similar distributions to those of
CRC in the pre-screening period, according to major charac-
teristics (except macro-area and number of lymph nodes).
Compared with the CRCs diagnosed before implementation of
the screening programmes, the probability of stage III or IV at
Total Areas with a screening programme Areas
period with screening without
N % pre-screening screen- not screen- a screening
period detected detected programme
Total (N) 23,668 100 6,710 2,806 6,759 7,393
Macro-area
Northwest 4,788 20.2 39.1 6.7 16.1 12.0
Northeast 11,571 48.9 52.2 74.4 47.6 37.4
Centre 4,066 17.2 8.7 18.9 36.4 6.7
South-Islands 3,243 13.7 0.0 0.0 0.0 43.9
Gender
male 4,043 59.3 58.8 61.7 60.0 158.3
female 9,625 40.7 41.2 38.4 40.0 41.7
Mean age (years) (SD) 61.8 (5.3) 61.8 (5.3) 62.3 (5.2) 61.7 (5.4) 61.7 (5.3)
Mean age (years)
50-54 2,954 12.5 12.5 9.9 13.6 12.5
55-59 4,787 20.2 19.8 20.2 19.6 21.2
60-64 6,821 28.8 29.4 28.2 28.3 29.0
65-69 9,106 38.5 38.3 41.7 38.5 37.4
Anatomic site
proximal colon 6,334 26.8 27.2 24.3 27.8 26.4
distal colon 8,603 36.4 37.8 50.6 35.7 30.2
rectum 7,487 31.6 31.2 23.2 32.5 34.5
colon NOS 1,244 5.3 3.9 2.0 4.0 8.9
Grading
well-differentiated 2,332 9.9 9.6 20.1 9.4 6.5
moderately differentiated 13,822 58.4 57.2 56.9 56.5 61.8
poorly differentiated 3,690 15.6 15.6 11.0 16.7 16.3
not available/missing 3,824 16.2 17.5 12.0 17.4 15.4
Lymph nodes examined
mean number (SD) 16.1 (9.9) 15.6 (9.3) 15.6 (9.7) 18.0 (11.0) 14.5 (8.7)
Positive lymph nodes
mean number (SD) 2.0 (4.2) 2.1 (4.0) 1.0 (2.7) 2.4 (4.9) 2.1 (4.2)
Positive lymph nodes in stage III/IV cases
mean number (SD) 4.3 (5.3) 4.2 (4.9) 3.4 (4.0) 4.6 (6.0) 4.3 (5.0)
Stage at diagnosis
I 4,495 19.0 16.2 42.8 17.2 14.2
II 5,722 24.2 24.9 19.1 24.4 25.2
III 6,267 26.5 27.5 20.1 28.3 26.3
IV 4,389 18.5 19.8 6.2 20.3 20.5
not available/missing 2,795 11.8 11.6 11.9 9.8 13.8
Table 3. Distribution of colo-
rectal cancer cases according to
main characteristics, by pattern
of diagnosis.
Tabella 3. Distribuzione dei
casi di tumore del colon retto
per varie caratteristiche, per mo-
dalità di diagnosi.
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diagnosis was reduced by 60% among screen-detected cases
(table 4, p. 112). Instead, there were no significant differences
regarding cases that were not screen-detected and cases diag-
nosed in areas with no screening. The risk of an advanced stage
decreased with age and was lower for cases of cancer located in
the distal colon and the rectum.
The probability of a poorly differentiated grading was signif-
icantly lower (14%) among screen-detected cases (table 5) as
compared to the period prior to screening, even when adjust-
ing for stage at diagnosis (OR not adjusted for stage was 0.62,
95%CI 0.54-0.71), while non-screen-detected cases and cases
diagnosed in areas with no screening did not show a different
risk from pre-screening CRCs. The risk of poorly differentiated
grading was higher in cases with an advanced stage at diagno-
sis and for cases located in the proximal colon.
DISCUSSION
Using data collected from the large number of CRCs diag-
nosed from 2000 to 2008, this study found that screen-de-
tected CRCs significantly differ from non-screen-detected
ones. In particular, the study confirms what is expected by the
diagnostic anticipation of screenings, i.e., more favourable
prognostic characteristics of screen-detected CRCs: a better
distribution by stage at diagnosis and by grading, and a
lower number of positive lymph nodes overall and for stage
III/IV cases.
Compared to non-screen-detected cases, the proportion of
screen-detected CRCs in males was higher, as was the mean age
of the patients.
We also observed a higher proportion of CRCs in the distal
colon. This figure could be due to the FIT’s higher sensitivity
to lesions of the left colon9-11 and hence to a higher impact on
the prevalence round of screening at this anatomic site. Most
screen-detected cases included in this study were diagnosed in
the first or second screening round, when many of the preva-
lent pre-clinical lesions are detected, thus producing a transient
increase in incidence rates. Another reason why screen-de-
tected CRCs are more frequent in the distal colon could de-
N stage III-IV* N stage I-II Odds ratio** 95%CI
Gender
male 6,249 6,104 1* -
female 4,407 4,113 1.02 0.97-1.08
Age (5-year linear increase) 0.91 0.89-0.94
Anatomic site
proximal colon 3,166 2,770 1* -
distal colon 3,647 4,019 0.83 0.77-0.88
rectum 3,226 3,026 0.91 0.84-0.97
colon NOS 617 402 1.19 1.04-1.37
N examined lymph nodes 1.002 1.001-1.003
Pattern of diagnosis
pre-screening 3,182 2,774 1* -
screen-detected 737 1,734 0.40 0.36-0.44
not screen-detected 3,566 3,090 1.04 0.97-1.12
areas with no screening 3,171 2,619 1.05 0.97-1.13
* reference
** estimated using logistic regression model (response variable stage III-IV vs. stage I-II), adjusted by all the variables in the table
Table 4. Odds ratios of colo-
rectal cancers diagnosed at
stage III or IV (as compared to
stage I-II), according to selec-
ted variables.
Tabella 4. Odds ratio di sta-
dio avanzato (III o IV), per di-
verse variabli.
N poorly N well mod. Odds ratio** 95%CI
differentiated* differentiated
Gender
male 2,120 9,627 1* -
female 1,570 6,527 1.07 1.00-1.16
Age (5-year linear increase) 1.00 0.96-1.03
Anatomic site
proximal colon 1,401 4,114 1* -
distal colon 1,104 6,411 0.54 0.49-0.59
rectum 980 4,973 0.61 0.56-0.68
colon NOS 205 656 0.93 0.78-1.11
N examined lymph nodes 1.00 0.998-1.00
Pattern of diagnosis
pre-screening 1,075 4,491 1* -
screen-detected 308 2,160 0.86 0.75-1.00
not screen-detected 1,298 4,859 1.06 0.96-1.16
areas with no screening 1,009 4,644 0.96 0.87-1.06
* reference
** estimated using logistic regression model (response variable stage III-IV vs. stage I-II), adjusted by all the variables in the table
Table 5. Odds ratios of poorly
differentiated grading colo-
rectal cancers (as compared
to well/moderately differen-
tiated), according to selected
variables.
Tabella 5. Odds ratio di gra-
ding scarsamente differenzia-
to, per diverse variabli.
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pend on the different biology of these lesions, that have been
associated to a slow natural history with a long pre-clinical
phase.12 This would increase the difference in diagnostic yield
of the distal versus the proximal colon.
Age was inversely correlated to the probability of stage III or
IV at diagnosis. The prevalence round of screening (which oc-
curs at a younger age) could play a role in this effect.
The number of lymph nodes examined was positively associ-
ated with a more advanced stage. The interpretation of this ef-
fect is controversial: on the one hand, the higher likelihood of
a staging upgrade the more lymph nodes are examined; on the
other hand, it could be hypothesized that more lymph nodes
are examined in more advanced cancers.
In areas with an SP, the proportion of screen-detected cases was
about one-third of the total. Besides the diagnostic sensitivity
of the first-level test and second-level assessment, this figure de-
pends on the extension of invitations and compliance with in-
vitation to screening. Even though this study monitored the
impact of screening in the first years after SP implementation
(when the spread of screening over the target population is rea-
sonably lower than expected in well-established programmes),
we observed a relevant impact of screening even when evalu-
ating all the CRCs diagnosed in the entire population.
Compared to the North-Centre, cases in the South and Islands
showed a worse distribution by stage at diagnosis and by grad-
ing. These figures suggest a diagnostic delay in this macro-area
that was worsened by the increase in the number of SPs in the
North-Centre. This hypothesis is in line with the results from
the latest report of the Italian association of cancer registries
(AIRTUM) on cancer patient survival. CRCs diagnosed dur-
ing 2001-2004 in the South and on the Islands showed a
lower 5-year survival rate compared to cases diagnosed in
other areas of Italy.13
Another important result of this study was that, after screening
was implemented, the cases diagnosed before the onset of an SP
and those not screen-detected in the same areas were very sim-
ilar in terms of distribution by age and anatomic site, stage at di-
agnosis, and grading.The only exception was the number of ex-
amined and positive lymph nodes, which was higher in the latter
group. However, this figure could be due to a period effect.
The cases that were diagnosed outside the SPs were not differ-
ent from the cases detected before the onset of screening.There-
fore, they do not seem to have been significantly affected by SP
implementation. This fact has at least three consequences:
 the presence of an SP does not seem to generate a “halo” ef-
fect (i.e., an increase in the spontaneous, extra-screening, up-
take of FIT and/or total colonoscopy) to produce a visible di-
agnostic anticipation; this hypothesis needs to be confirmed in
areas where SPs have been active for more years;
 non-screen-detected cases are representative of the cases that
were diagnosed in the absence of SPs, therefore they can be safe-
ly used as a comparison group for screen-detected CRCs;
 the differences that we observed in the screen-detected cas-
es may be entirely attributed to the specific pattern of diagnosis.
The risk of selection bias (i.e., compliance with the screening
invitation being higher among healthier subjects, who would
have a more favourable pattern of disease even without an SP)
seems unlikely. Otherwise, non-screen-detected cases would have
shown worse characteristics than cases diagnosed before the on-
set of screening.
This is in line with data from a national survey on preventive
behaviours and service utilization, which showed that in Italy
spontaneous screening for CRC is very low and the coverage
in regions with well-implemented population-based SPs is
higher among subjects with a lower educational level.14
However, this picture could be modified as SPs age and fol-
lowing changes in compliance with invitation.
CONCLUSION
Screen-detected CRCs showed a favourable distribution by dif-
ferent prognostic factors, while cases diagnosed in the South
and on the Islands reported the worst figures.
A renewed effort to implement screening programmes through-
out the entire country, and particularly in the South and on the
Islands, is therefore warranted, filling the prognostic gap
among geographic areas, to increase the equity of access to a
public health programme that is proving to be highly protec-
tive of the population.
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